Ventyx Biosciences, Inc. (VTYX)
13.88
-0.02
(-0.11%)
USD |
NASDAQ |
Jan 20, 16:00
13.83
-0.04
(-0.32%)
After-Hours: 20:00
Ventyx Biosciences EPS Diluted (Quarterly): -0.3202 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Revolution Medicines, Inc. | -1.613 |
| BioAge Labs, Inc. | -0.5626 |
| Vera Therapeutics, Inc. | -1.258 |
| Neumora Therapeutics, Inc. | -0.3507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.83M |
| Total Expenses (Quarterly) | 22.83M |
| Enterprise Value | 808.56M |
| Earnings Yield | -10.81% |
| Normalized Earnings Yield | -10.79 |